Pages that link to "Q44860005"

The following pages link to Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma (Q44860005):

Displaying 40 items.

• Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity (Q24523292) (← links)
• Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies (Q27002547) (← links)
• The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling (Q28564678) (← links)
• Cholangiocarcinoma: Current concepts and insights (Q33965702) (← links)
• Cholangiocarcinoma: modern advances in understanding a deadly old disease (Q34000079) (← links)
• Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies (Q34253944) (← links)
• Pathogenesis, diagnosis, and management of cholangiocarcinoma (Q34656747) (← links)
• Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment (Q34803024) (← links)
• Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). (Q35045355) (← links)
• Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA (Q35085981) (← links)
• Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver (Q35745449) (← links)
• HER2/neu-directed therapy for biliary tract cancer (Q35748129) (← links)
• JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression? (Q36178175) (← links)
• Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment (Q36950063) (← links)
• Leptin enhances cholangiocarcinoma cell growth (Q36915317) (← links)
• Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells (Q37141943) (← links)
• c-Met targeted therapy of cholangiocarcinoma (Q37169357) (← links)
• Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. (Q37226551) (← links)
• Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma (Q37351498) (← links)
• A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. (Q37719383) (← links)
• Genetics of biliary tract cancers and emerging targeted therapies (Q37765099) (← links)
• Molecular mechanisms of cholangiocarcinoma (Q37878879) (← links)
• Molecular aspects of cholangiocarcinoma (Q38178190) (← links)
• Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer (Q38993903) (← links)
• MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells (Q39413378) (← links)
• Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy (Q39683530) (← links)
• A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines (Q40035334) (← links)
• Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation (Q40571173) (← links)
• Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma (Q40820874) (← links)
• A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods (Q41886849) (← links)
• Liver damage using suicide genes. A model for oval cell activation (Q42048659) (← links)
• Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet (Q42060696) (← links)
• Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan (Q43128717) (← links)
• Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furan (Q43177447) (← links)
• Phenotypic characteristics and proliferative activity of hyperplastic ductule cells in cholangiofibrosis induced by thioacetamide in rats (Q45834101) (← links)
• c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma (Q52122642) (← links)
• Animal models of cholangiocarcinoma. (Q52720960) (← links)
• Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma. (Q55032209) (← links)
• Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma (Q80094301) (← links)
• Cystic cholangiomas after transplantation of pancreatic islets into the livers of diabetic rats (Q83120973) (← links)